Cargando...

RB-pathway Disruption is Associated with Improved Response to Neoadjuvant Chemotherapy in Breast Cancer

PURPOSE: We sought to determine whether dysregulation of the RB tumor suppressor pathway was associated with improved response to neoadjuvant chemotherapy in breast cancer. EXPERIMENTAL DESIGN: An RB-loss signature was used to analyze the association between pathway status and pathological complete...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Cancer Res
Autores principales: Witkiewicz, Agnieszka K., Ertel, Adam, McFalls, Jeanne, Valsecchi, Matias E, Schwartz, Gordon, Knudsen, Erik S.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2012
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4436088/
https://ncbi.nlm.nih.gov/pubmed/22811582
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-12-0903
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!